Aethlon Medical Inc. is a medical technology company focused on developing immunotherapeutic products for cancer and infectious disease. Its primary platform, the Aethlon Hemopurifier, is designed to reduce cancer-promoting exosomes and circulating viruses through extracorporeal blood filtration. The company’s work centers on clinical-stage solutions that address life- and organ-threatening conditions, with applications that intersect oncology, virology, and critical care medicine. Aethlon Medical serves the broader healthcare market by advancing device-based technologies intended for diagnostic and therapeutic use in severe diseases. Headquartered in San Diego, California, Aethlon Medical Inc. operates as a specialized developer of highly targeted medical treatments within the biotechnology and medical device sectors.